Nigeria Starts Local Production of Antiretroviral AIDS Drugs
March 12, 2004
Nigerian health officials announced the nation has begun local production of HIV/AIDS antiretroviral drugs, which it introduced into the Nigerian market on Thursday. Figures show 5.4 percent of Nigeria's 126 million people have HIV, and there are concerns that the rate is rising. Nigeria launched the first trial of generic AIDS drugs imported from India in December 2001. Health Minister Eyitayo Lambo said the launch of AVOLAM (lamivudine), Azido (zidovudine) and NEVRAN (nevirapine) by Ranbaxy Nigeria Limited will provide greater access to treatment and that the government hopes to achieve more than 80 percent local production of generic drugs within the next three years. The drugs will be distributed to designated treatment centers at subsidized rates, the minister said.Adapted from:
Agence France Presse
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.